Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
8-K
| Quarterly results|
Docs:
|
"Assets Current assets Cash and cash equivalents $ 63,212 $ 21,929 Accounts receivable 46,553 54,826 Net investment in leases 13,219 16,130 Inventories 20,315 23,124 Income taxes receivable 1,779 — Prepaid expenses and other current assets 4,480 3,754 Total current assets 149,558 119,763 Non-current assets Property and equipment, net 5,771 6,077 Right of use operating lease assets 20,041 21,322 Intangible assets, net 48,559 50,375 Goodwill 31,063 31,063 Accounts receivable, non-current 15,430 23,061 Other non-current assets 3,306 3,335 Total non-current assets 124,170 135,233 Total assets $ 273,728 $ 254,996 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 9,296 $ 9,984 Note payable 2,968 2,968 Earn-out, current 9,280 13,050 Accrued payroll and related taxes 13,80..." |
|
| 07/18/2023 |
8-K
| Quarterly results |
| 05/09/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/08/2023 |
8-K
| Quarterly results |
| 03/14/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/28/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Underwriting Agreement, between the Company and William Blair & Company, L.L.C., as the underwriter",
"Opinion of Faegre Drinker Biddle & Reath LLP",
"Tactile Systems Technology, Inc. Announces Proposed Public Offering of Common Stock MINNEAPOLIS, Minn.——Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. Tactile Medical intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the proposed offering will be sold by Tactile Medical. The offering is subject to market and other conditions, ...",
"Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock MINNEAPOLIS, Minn.—— Feb. 23, 2023— Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $13.00 per share. The gross proceeds to Tactile Medical from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be $32.5 million. Additionally, Tactile Medical has granted the underwriter a 30-day option to purchase up to an additional 375,000 shares of its common stock at the public o..." |
|
| 01/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/23/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 11/29/2022 |
8-K
| Quarterly results |
| 11/07/2022 |
8-K
| Quarterly results|
Docs:
|
"Third Quarter Revenue Increased 24% Year-Over-Year; First Nine Months Revenue Increased 18% Year-Over-Year MINNEAPOLIS, MN, November 7, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2022. Third Quarter 2022 Summary: ● Total revenue increased 24% year-over-year to $65.3 million, compared to $52.5 million in third quarter 2021. ● Total revenue in third quarter 2022 included $11.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021, compared to $0.9 million of revenue in third qu..." |
|
| 08/01/2022 |
8-K
| Quarterly results|
Docs:
|
"Second Quarter Revenue Increased 17% Year-Over-Year; First Half Revenue Increased 15% Year-Over-Year MINNEAPOLIS, MN, August 1, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the second quarter and six months ended June 30, 2022. Second Quarter 2022 Summary: ● Total revenue increased 17% year-over-year to $59.6 million, compared to $51.1 million in second quarter 2021. ● Total revenue in second quarter 2022 included $8.0 million of revenue from sales of airway clearance products, which includes the AffloVest product line acquired on September 8, 2021. ● Operating loss of $4.1 million, compared to $0.1 m..." |
|
| 05/10/2022 |
8-K
| Quarterly results |
| 05/02/2022 |
8-K
| Quarterly results |
| 02/22/2022 |
8-K
| Quarterly results|
Docs:
|
"Fourth Quarter Revenue Increased 4% Year-Over-Year; Full Year Revenue Increased 11% Year-over-Year MINNEAPOLIS, MN, February 22, 2022 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today reported financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter 2021 Summary: ● Total revenue increased 4% year-over-year to $61.7 million, compared to $59.2 million in fourth quarter 2020. ● Total revenue in fourth quarter 2021 included $4.3 million of revenue from the AffloVest respiratory therapy business, acquired on September 8, 2021. ● Operating income of $3.8 million, compared to operating income of $7.0 million in..." |
|
| 02/22/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 01/05/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/08/2021 |
8-K
| Quarterly results |
| 09/08/2021 |
8-K
| Quarterly results |
| 08/02/2021 |
8-K
| Quarterly results|
Docs:
|
"Second Quarter Revenue Increased 45% Year-Over-Year; First Half Revenue Increased 19% Year-over-Year MINNEAPOLIS, MN, August 2, 2021 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the second quarter and six months ended June 30, 2021. Second Quarter 2021 Summary: ● Total revenue increased 45% year-over-year to $51.1 million, compared to $35.1 million in second quarter 2020. ● Operating loss of $0.1 million, compared to operating loss of $8.0 million in second quarter 2020. ● Net income of $1.3 million, compared to net loss of $13.9 million in second quarter 2020. ● Adjusted EBITDA of $4.1 million, compared to Adjusted EBITDA lo..." |
|
| 05/18/2021 |
8-K
| Quarterly results |
| 05/03/2021 |
8-K
| Quarterly results |
| 04/20/2021 |
8-K
| Quarterly results |
| 03/12/2021 |
8-K
| Quarterly results |
| 02/23/2021 |
8-K
| Quarterly results |
| 01/05/2021 |
8-K
| Quarterly results |
| 11/02/2020 |
8-K
| Quarterly results|
Docs:
|
"Third Quarter Revenue Decreased 1% Year-Over-Year; Flat Year-Over-Year on an Operational Basis First Nine Months Revenue Decreased 3% Year-over-Year; Flat Year-over-Year on an Operational Basis MINNEAPOLIS, MN, November 2, 2020 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today reported financial results for the third quarter and nine months ended September 30, 2020. Third Quarter 2020 Summary: ● Total revenue decreased 1% year-over-year, to $49.1 million, compared to $49.6 million in third quarter 2019. o Excluding the contribution to third quarter 2019 revenue related to the Company’s adoption of ASC 842, third quarter 2020 revenue reflects a flat year-over-year change on an op..." |
|
| 09/03/2020 |
8-K
| Quarterly results |
| 08/03/2020 |
8-K
| Quarterly results |
| 05/22/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Tactile Systems Technology, Inc. Announces Appointment of Daniel L. Reuvers as President and Chief Executive Officer MINNEAPOLIS, MN, May 21, 2020 – Tactile Systems Technology, Inc. , a medical technology company focused on developing medical devices for the at-home treatment of chronic diseases, today announced that Daniel L. Reuvers has been appointed President and Chief Executive Officer, effective June 8, 2020, to succeed Gerald R. Mattys who is retiring, as previously disclosed. Mr. Reuvers will also join the Board of Directors, effective June 8, 2020, filling a seat created by Mr. Mattys’ retirement from the Board, effective that same day. Mr. Mattys will serve as a consultant to the Company until June 2021 to ensure a seamless transition. “After a comprehensive search process which ..." |
|
| 05/07/2020 |
8-K
| Quarterly results |
| 05/04/2020 |
8-K
| Quarterly results |
| 04/07/2020 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/26/2020 |
8-K
| Quarterly results |
|
|
|